J M Lainez Andres

Summary

Country: Spain

Publications

  1. ncbi Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy
    M J A Lainez
    Neurology Department, Hospital Clinic Universitari, University of Valencia, Valencia, Spain
    Eur J Neurol 14:269-75. 2007
  2. doi Headache after trauma: physiological considerations
    Miguel J A Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain
    Curr Pain Headache Rep 15:467-73. 2011
  3. ncbi [Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)]
    J M Lainez-Andres
    Servicios de Neurologia, Hospital Clinico Universitario, Universidad Católica de Valencia, Espana
    Rev Neurol 56:143-51. 2013
  4. ncbi [Onabotulinumtoxin A in the treatment of chronic migraine]
    José M Láinez-Andrés
    Servicio de Neurologia, Hospital Clinico Universitario, Universidad Católica de Valencia, Valencia, Espana
    Rev Neurol 54:S39-50. 2012
  5. pmc Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA
    Deborah A Hall
    NIHR National Biomedical Research Unit in Hearing, Nottingham, UK
    BMC Health Serv Res 11:302. 2011
  6. ncbi Clinical benefits of early triptan therapy for migraine
    Mja Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain
    Cephalalgia 24:24-30. 2004
  7. pmc New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care
    Miguel J Láinez
    Department of Neurology, University Hospital of Valencia, Valencia, Spain
    BMC Neurol 10:39. 2010
  8. doi The effect of migraine prophylaxis on migraine-related resource use and productivity
    Miguel J A Láinez
    Department of Neurology, Hospital Clinico Universitario, Universidad de Valencia, 46010 Valencia, Spain
    CNS Drugs 23:727-38. 2009
  9. ncbi Chronic daily headache
    M J Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Avda Blasco Ibanez 17, Valencia 46010, Spain
    Curr Neurol Neurosci Rep 1:118-24. 2001
  10. ncbi Almotriptan: meeting today's needs in acute migraine treatment
    Miguel J A Láinez
    Department of Neurology, University Clinic Hospital, University of Valencia, Avda Blasco Ibanez, 17 46010 Valencia, Spain
    Expert Rev Neurother 7:1659-73. 2007

Collaborators

  • C Allen
  • P Irimia
  • N A Rao
  • S Evers
  • J Galvan
  • Jesus Castillo
  • Miguel J A Láinez
  • M J A Lainez
  • J M Lainez-Andres
  • José M Láinez-Andrés
  • Deborah A Hall
  • Miguel J Láinez
  • Mja Láinez
  • M D Jiménez-Hernández
  • A Caminero
  • R Leira
  • M Sanchez Del Rio-Gonzalez
  • M Huerta-Villanueva
  • S Diaz-Insa
  • M Gracia-Naya
  • M J Láinez
  • Frank Tennigkeit
  • Tanit Ganz Sanchez
  • Berthold Langguth
  • Marco Koch
  • Craig W Newman
  • Begoña López Pesquera
  • Martin Egler
  • Javier Rejas
  • Silvia Diaz
  • Manuel Dominguez
  • Gemma Palacios
  • S Ascher
  • W H Olson
  • J Pfeil
  • C Vila
  • S Schwalen
  • F G Freitag
  • J Heras
  • K Lis
  • E Kinge
  • R Massaad
  • G Allais
  • M J Monzón

Detail Information

Publications16

  1. ncbi Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy
    M J A Lainez
    Neurology Department, Hospital Clinic Universitari, University of Valencia, Valencia, Spain
    Eur J Neurol 14:269-75. 2007
    ..In conclusion, almotriptan was associated with significantly greater efficacy for treating migraine compared with ergotamine plus caffeine, was generally well tolerated and was associated with greater rate of treatment satisfaction...
  2. doi Headache after trauma: physiological considerations
    Miguel J A Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain
    Curr Pain Headache Rep 15:467-73. 2011
    ....
  3. ncbi [Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)]
    J M Lainez-Andres
    Servicios de Neurologia, Hospital Clinico Universitario, Universidad Católica de Valencia, Espana
    Rev Neurol 56:143-51. 2013
    ..At the same time it sought to establish a predictive model that can be used to recommend one or another, depending on those characteristics...
  4. ncbi [Onabotulinumtoxin A in the treatment of chronic migraine]
    José M Láinez-Andrés
    Servicio de Neurologia, Hospital Clinico Universitario, Universidad Católica de Valencia, Valencia, Espana
    Rev Neurol 54:S39-50. 2012
    ..In sum, OnabotA is a safe, well-tolerated alternative in the preventive treatment of chronic migraine...
  5. pmc Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA
    Deborah A Hall
    NIHR National Biomedical Research Unit in Hearing, Nottingham, UK
    BMC Health Serv Res 11:302. 2011
    ....
  6. ncbi Clinical benefits of early triptan therapy for migraine
    Mja Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain
    Cephalalgia 24:24-30. 2004
    ..Early intervention is recommended to avoid the significant pain and disability commonly associated with moderate or severe migraine...
  7. pmc New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care
    Miguel J Láinez
    Department of Neurology, University Hospital of Valencia, Valencia, Spain
    BMC Neurol 10:39. 2010
    ..The aim of the study was to validate the self-administered MS-Q questionnaire for detection of hidden migraine in the field of primary care (PC), and to explore its use in this setting...
  8. doi The effect of migraine prophylaxis on migraine-related resource use and productivity
    Miguel J A Láinez
    Department of Neurology, Hospital Clinico Universitario, Universidad de Valencia, 46010 Valencia, Spain
    CNS Drugs 23:727-38. 2009
    ..For both health-plan payers and employers, topiramate appears to be a cost-effective intervention for preventing migraine...
  9. ncbi Chronic daily headache
    M J Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Avda Blasco Ibanez 17, Valencia 46010, Spain
    Curr Neurol Neurosci Rep 1:118-24. 2001
    ..Analgesic or ergot overuse is frequent in all types of CDH. We review recent insights into the proposed classification, epidemiology, pathophysiology, clinical characteristics, and treatment of CDH...
  10. ncbi Almotriptan: meeting today's needs in acute migraine treatment
    Miguel J A Láinez
    Department of Neurology, University Clinic Hospital, University of Valencia, Avda Blasco Ibanez, 17 46010 Valencia, Spain
    Expert Rev Neurother 7:1659-73. 2007
    ....
  11. ncbi Time course of adverse events most commonly associated with topiramate for migraine prevention
    M J A Lainez
    University Clinic Hospital, University of Valencia, Valencia, Spain
    Eur J Neurol 14:900-6. 2007
    ..AEs leading to discontinuation of topiramate are probably to occur during dose titration. If a patient has not experienced one of these AEs within the first 6 weeks of initiating topiramate 100 mg/day, these AEs are unlikely to occur...
  12. ncbi Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine
    M J A Lainez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain
    Cephalalgia 26:246-56. 2006
    ..The single most important reason for preference was speed of relief, consistent with results from previous preference studies...
  13. pmc Chronic headaches: from research to clinical practice
    Miguel J A Láinez
    Department of Neurology, Hospital Clinico Universitario, University of Valencia, Avda Blasco Ibanez 17, 46010, Valencia, Spain
    J Headache Pain 6:175-8. 2005
    ..Analgesics, ergots and triptan overuse are frequent in all types of CDH. We revise recent insights into the epidemiology, pathophysiology, clinical characteristics and prognosis of CDH...
  14. ncbi [Migraine and quality of life]
    J M Lainez Andres
    Unidad de Cefaleas, Hospital General Universitario, Universidad de Valencia
    Neurologia 13:1-8. 1998
    ....